Search details
1.
p53 activation during ribosome biogenesis regulates normal erythroid differentiation.
Blood
; 137(1): 89-102, 2021 01 07.
Article
in English
| MEDLINE | ID: mdl-32818241
2.
BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.
Int J Mol Sci
; 22(19)2021 Sep 30.
Article
in English
| MEDLINE | ID: mdl-34638998
3.
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS/BCL-2 mouse model of AML by targeting primitive LSK and progenitor cells.
Blood
; 122(16): 2864-76, 2013 Oct 17.
Article
in English
| MEDLINE | ID: mdl-23943652
4.
Identification of a Patient Cohort with Relapsing Diffuse Large B-Cell Lymphoma with a Low International Prognostic Index in PET/CT Using a 2-Gene (LMO2/TNFRSF9) Scoring System.
Acta Haematol
; 143(6): 600-602, 2020.
Article
in English
| MEDLINE | ID: mdl-32187599
5.
Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?
Haematologica
; 98(1): 10-22, 2013 Jan.
Article
in English
| MEDLINE | ID: mdl-23065517
6.
Tracking the extramedullary PML-RARα-positive cell reservoirs in a preclinical model: biomarker of long-term drug efficacy.
Mol Cell Probes
; 27(1): 1-5, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-22906630
7.
DNA vaccination with all-trans retinoic acid treatment induces long-term survival and elicits specific immune responses requiring CD4+ and CD8+ T-cell activation in an acute promyelocytic leukemia mouse model.
Blood
; 115(3): 653-6, 2010 Jan 21.
Article
in English
| MEDLINE | ID: mdl-19965687
8.
Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Signal Transduct Target Ther
; 7(1): 51, 2022 02 21.
Article
in English
| MEDLINE | ID: mdl-35185150
9.
PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia.
Nat Med
; 9(11): 1413-7, 2003 Nov.
Article
in English
| MEDLINE | ID: mdl-14566333
10.
Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?
Cancer Res
; 67(18): 8762-71, 2007 Sep 15.
Article
in English
| MEDLINE | ID: mdl-17875717
11.
The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.
Cell Death Differ
; 26(9): 1813-1831, 2019 09.
Article
in English
| MEDLINE | ID: mdl-30538287
12.
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
Front Immunol
; 9: 1357, 2018.
Article
in English
| MEDLINE | ID: mdl-29963052
13.
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?
Mol Cancer Res
; 4(8): 563-73, 2006 Aug.
Article
in English
| MEDLINE | ID: mdl-16877702
14.
BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia.
Oncotarget
; 8(29): 47103-47109, 2017 Jul 18.
Article
in English
| MEDLINE | ID: mdl-28514758
15.
The effect of biological heterogeneity on R-CHOP treatment outcome in diffuse large B-cell lymphoma across five international regions.
Leuk Lymphoma
; 58(5): 1178-1183, 2017 05.
Article
in English
| MEDLINE | ID: mdl-27724056
16.
Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Signal Transduct Target Ther
; 7(1): 110, 2022 Apr 01.
Article
in English
| MEDLINE | ID: mdl-35365596
17.
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.
J Hematol Oncol
; 9: 5, 2016 Jan 27.
Article
in English
| MEDLINE | ID: mdl-26817437
18.
Protocol for qRT-PCR analysis from formalin fixed paraffin embedded tissue sections from diffuse large b-cell lymphoma: Validation of the six-gene predictor score.
Oncotarget
; 7(50): 83319-83329, 2016 Dec 13.
Article
in English
| MEDLINE | ID: mdl-27825111
19.
DNA-mediated adjuvant immunotherapy extends survival in two different mouse models of myeloid malignancies.
Oncotarget
; 6(32): 32494-508, 2015 Oct 20.
Article
in English
| MEDLINE | ID: mdl-26378812
20.
Comparison of newly diagnosed and relapsed patients with acute promyelocytic leukemia treated with arsenic trioxide: insight into mechanisms of resistance.
PLoS One
; 10(3): e0121912, 2015.
Article
in English
| MEDLINE | ID: mdl-25822503